Neurometrix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 9.81, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Neurometrix Inc in Dec 31 2024 quarter, has decreased to 37 days, compared to 46 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 120 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1290, from overall ranking in the third quarter 2024 at 1540.

What is Receivable Turnover Ratio?
What is Neurometrix Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NURO Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-62.82 %	-75.73 %	-62.43 %	-18.5 %	-19.78 %
Y / Y Revenue Change	-36.86 %	-51.19 %	-53.55 %	-36.6 %	-80.31 %
Receivable Turnover Ratio (TTM)	9.81	7.94	7.28	7.35	8.06
NURO's Total Ranking	# 1290	# 1540	# 1118	# 1401	# 1157
Accounts Receivable average collection period days	37	46	50	50	45
Seq. Receivable Change	29.39 %	-46.86 %	-40.26 %	-9.48 %	-15.55 %
Seq. Revenue Change	-60.9 %	-23.64 %	-29.67 %	200.65 %	-69.77 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 37
Healthcare Sector	# 121
Overall Market	# 1290

Receivable Turnover Ratio Statistics
High	Average	Low
22.77	13.34	7.28
(Mar 31 2017)		(Jun 30 2024)

NURO Company Profile • Back to NURO Efficiency Comparisons • Compare NURO Receivables Turnover Ratio to its Competitors

Financial Statements
Neurometrix Inc 's Accounts Receivable	$ 0 Millions	Visit NURO's Balance sheet
Neurometrix Inc 's Sales TTM	$ 3 Millions	Visit NURO's Income Statement
Sources of NURO's Revenues		Visit NURO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NURO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NURO's Growth Rates	NURO's Roa	NURO's Inventory Turnover Ratio	NURO's Dividend Comparisons
NURO's Profitability Ratios	NURO's Roi	NURO's Asset Turnover Ratio	NURO's Dividend Growth
NURO's Valuation Ratios	NURO's Roe	NURO's Financial Strength Ratios	NURO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Metagenomi Therapeutics Inc	37.51	$ 52.295 Millions	$ 1.394 Millions
Curevac N v	34.33	$ 599.402 Millions	$ 17.462 Millions
Blue Water Vaccines Inc	33.93	$ 2.524 Millions	$ 0.074 Millions
One World Products Inc	33.83	$ 0.005 Millions	$ 0.000 Millions
Lifemd Inc	33.53	$ 211.815 Millions	$ 6.318 Millions
Xoma Royalty Corporation	33.39	$ 28.487 Millions	$ 0.853 Millions
Vivos Therapeutics Inc	33.30	$ 15.019 Millions	$ 0.451 Millions
Electrocore Inc	33.28	$ 24.397 Millions	$ 0.733 Millions
Eyepoint Inc	32.20	$ 43.273 Millions	$ 1.344 Millions
Keros Therapeutics Inc	32.20	$ 27.046 Millions	$ 0.840 Millions
Aesthetic Medical International Holdings Group Limited	31.87	$ 112.161 Millions	$ 3.519 Millions
Newgenivf Group Limited	31.82	$ 5.433 Millions	$ 0.171 Millions
Galapagos Nv	31.65	$ 308.727 Millions	$ 9.753 Millions
National Vision Holdings Inc	31.43	$ 1,823.320 Millions	$ 58.018 Millions
Aquestive Therapeutics Inc	31.35	$ 57.561 Millions	$ 1.836 Millions
Invo Fertility Inc	30.17	$ 6.532 Millions	$ 0.217 Millions
Orchestra Biomed Holdings Inc	29.81	$ 2.638 Millions	$ 0.089 Millions
U S Physical Therapy Inc	29.80	$ 671.345 Millions	$ 22.531 Millions
Agape Atp Corporation	29.20	$ 1.323 Millions	$ 0.045 Millions
Cv Sciences Inc	29.03	$ 15.168 Millions	$ 0.523 Millions
Lineage Cell Therapeutics Inc	28.04	$ 9.499 Millions	$ 0.339 Millions
Fonar Corporation	27.81	$ 101.570 Millions	$ 3.652 Millions
Monte Rosa Therapeutics Inc	26.98	$ 75.622 Millions	$ 2.803 Millions
Evotec Se	25.61	$ 892.603 Millions	$ 34.857 Millions
Pulmatrix Inc	25.43	$ 7.806 Millions	$ 0.307 Millions
Nutriband Inc	25.42	$ 2.140 Millions	$ 0.084 Millions
Atara Biotherapeutics Inc	25.32	$ 259.990 Millions	$ 10.268 Millions
Cytomx Therapeutics Inc	24.65	$ 138.103 Millions	$ 5.602 Millions
Euda Health Holdings Limited	24.56	$ 3.762 Millions	$ 0.153 Millions
Adaptimmune Therapeutics Plc	24.06	$ 178.032 Millions	$ 7.399 Millions

Date modified: 2026-09-08T15:11:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.